Emily Gottschalk insider trades

Open-market stock purchases and sales by Emily Gottschalk, Director at Anixa Biosciences Inc, from SEC Form 4 filings since Oct 23, 2019.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -44%.

Recent trades

DateStockTradeValue
Jan 5, 2026ANIX Anixa Biosciences IncBought (not open market)—

Companies traded

  • ANIX Anixa Biosciences Inc: 3 buys, last Jan 5, 2026

Get free alerts when Emily Gottschalk files a new trade →